Benjamin Belot’s Post

Thoughts on this? >> Nvelop launches with $100M, advancing David Liu, Keith Joung gene editing delivery work >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #productmarketing #pharma #biotech

Thoughts on this? >> Nvelop launches with $100M, advancing David Liu, Keith Joung gene editing delivery work >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #pharma #healthcare #biotech

Global #Genome #Editing Market: By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery, Gene-modified Cell Therapy, Diagnostics, and Other Applications), By Technology (CRISPR, TALEN, ZFN, and Other Technologies), By End User (Academics & Government Institutes, Biotechnology & Pharma Companies, and Contract Research Organizations), and Region : Cumulative Growth Opportunities Analysis, Size, Share, Trends, and Industry Forecast Till 2030. By: Analytical Market Research Read More Info:https://lnkd.in/dVdCccsT Key Players: CRISPR Therapeutics , GenScript , Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, PerkinElmer., Eurofins Scientific Finland Oy, Danaher Corporation, Editas Medicine, AL Group Lonza . #marketgrowth #marketshare #marketsize #marketdemands #marketforecast #marketstretargy #marketanalysis #markettrends #market

Global #Genome #Editing Market: By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery, Gene-modified Cell Therapy, Diagnostics, and Other Applications), By Technology (CRISPR, TALEN, ZFN, and Other Technologies), By End User (Academics & Government Institutes, Biotechnology & Pharma Companies, and Contract Research Organizations), and Region – Cumulative Growth Opportunities Analysis, Size, Share, Trends, and Industry Forecast Till 2030. By:Analytical Market Research Read More Info:https://lnkd.in/dVdCccsT Key Players: CRISPR Therapeutics , GenScript , Thermo Fisher Scientific, INC., Merck KGaA, Darmstadt, Germany, PerkinElmer., Eurofins Scientific Finland Oy, Danaher Corporation, Editas Medicine, Lonzagroup.it . #marketgrowth #marketshare #marketsize #marketdemands #marketforecast #marketstretargy #marketanalysis #markettrends #market

🌟 Speaker Spotlight: Sam Albeke🌟 Join us at the Extractables & Leachables Summit West 2024, as we welcome Sam Albeke, Chromatography Manager at Element Materials Technology. Sam started his career as an R&D chemist formulating coating formulations with the same additives that he now spends his time detecting and identifying in the extractables and leachables industry. Sam has a vast expertise in overcoming the analytical challenges that can present themselves when performing E&L data analysis. Sam’s talk will explore the use of fluoropolymers like FEP in single-use components for Cell & Gene Therapy manufacturing and the concern over PFAS migration into these products. He’ll present a case study that looks at identifying PFAS in FEP, what causes this migration, and how it affects patient safety. Sam will also cover feedback from regulators, opening up a discussion on how the CGT industry can work together to set better standards and keep therapies safe. Don't miss this insightful session from a leading expert in the field! 💥 #PharmaEvents #Pharmaceuticals #ExtractablesAndLeachables #MaterialSelection #PatientSafety #DrugDevelopment #GCMS #DrugSafety #EandL #AnalyticalChemistry #PharmaIndustry #Biopharma #Element

Based on the Global #Cell_Based_Assays Market Analysis by Value Market Research: Market Demand to Grow Steadily between 2023 to 2032. >> https://lnkd.in/dyuynNAt Cell-based #assays are experimental techniques for studying #cellular processes, #interactions, and responses to external stimuli or compounds. They involve culturing #cells in vitro and measuring specific cellular #functions, such as proliferation, viability, #apoptosis, migration, differentiation, or #gene expression. These assays are widely used in basic research, #drug discovery, toxicity #testing, and drug screening to investigate disease #mechanisms, evaluate drug efficacy and #safety, and identify potential #therapeutic targets or compounds. Danaher Corporation GE HealthCare Charles River Laboratories AL Group Lonza Thermo Fisher Scientific Merck Group PerkinElmer Cell Signaling Technology (CST) Becton Dickenson Promega Corporation Cell Based Assays #healthcareindustry #pharmaceuticalindustry #healthcareresearch #biotechnology #assays #cellular #gene #research

In this new Cell & Gene article, BioPhorum discusses how #cellandgenetherapy companies can use prior knowledge and platforms to leverage process characterization to reduce the testing and/or studies required during process validation for drug substance and drug product manufacturing processes. https://lnkd.in/e-6-6AZT #cellandgenetherapies #processdevelopment #biotech BioPhorum Advanced Therapy Medicinal Products

Thoughts on this? >> Scientists unveil new way to make large changes to genes, and no CRISPR is required >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #pharmaceutical #healthcare

Thoughts on this? >> Scientists unveil new way to make large changes to genes, and no CRISPR is required >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #biotech #pharmaceutical #healthcare

#Article now available! Simplifying residual #DNAquantitation and #biotherapeuticmanufacturing Meeting regulatory guidelines for any biologic depends on robust #productcharacterization. In this article, Ilaria Scarfone (Field Application Scientist, Pharma Analytics, Thermo Fisher Scientific) explores the challenges in the development of residual #DNAassays and presents a comprehensive commercial solution to help save time and cost in the development process Read below: